Ubs Asset Management Americas Inc Medpace Holdings, Inc. Transaction History

Ubs Asset Management Americas Inc

$381 Billion
Q3 2024

A detailed history of Ubs Asset Management Americas Inc transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 83,435 shares of MEDP stock, worth $25.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

83,435

Previous 144,148 42.12%

Holding current value

$25.9 Million

Previous $59.4 Million 53.13%

% of portfolio

0.01%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$320.58 - $457.29 $19.5 Million - $27.8 Million	-60,713 Reduced 42.12%	83,435 $27.8 Million
Q2 2024 Aug 13, 2024	BUY	$372.0 - $424.34 $10.9 Million - $12.5 Million	29,432 Added 25.66%	144,148 $59.4 Million
Q1 2024 May 15, 2024	SELL	$284.87 - $413.31 $143,289 - $207,894	-503 Reduced 0.44%	114,716 $46.4 Million
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $17,291 - $23,763	-76 Reduced 0.07%	115,219 $35.3 Million
Q3 2023 Nov 13, 2023	SELL	$233.98 - $281.67 $18.1 Million - $21.8 Million	-77,567 Reduced 40.22%	115,295 $27.9 Million
Q1 2023 May 15, 2023	BUY	$174.31 - $239.52 $33.6 Million - $46.2 Million	192,862 New	192,862 $36.3 Million
Q3 2022 Nov 14, 2022	SELL	$145.13 - $182.49 $2.58 Million - $3.24 Million	-17,758 Reduced 12.69%	122,175 $19.2 Million
Q2 2022 Aug 12, 2022	SELL	$130.2 - $168.03 $131,892 - $170,214	-1,013 Reduced 0.72%	139,933 $20.9 Million
Q1 2022 May 16, 2022	SELL	$138.87 - $214.31 $936,539 - $1.45 Million	-6,744 Reduced 4.57%	140,946 $23.1 Million
Q4 2021 Feb 14, 2022	SELL	$182.74 - $227.9 $35,817 - $44,668	-196 Reduced 0.13%	147,690 $32.1 Million
Q3 2021 Nov 15, 2021	SELL	$170.18 - $198.21 $336,956 - $392,455	-1,980 Reduced 1.32%	147,886 $28 Million
Q2 2021 Aug 16, 2021	SELL	$158.62 - $194.3 $1.19 Million - $1.46 Million	-7,533 Reduced 4.79%	149,866 $26.5 Million
Q1 2021 May 14, 2021	SELL	$132.02 - $168.26 $56,504 - $72,015	-428 Reduced 0.27%	157,399 $25.8 Million
Q4 2020 Mar 01, 2021	SELL	$109.38 - $149.19 $666,233 - $908,716	-6,091 Reduced 3.72%	157,827 $22 Million
Q3 2020 Nov 13, 2020	BUY	$92.95 - $130.61 $12.4 Million - $17.4 Million	133,539 Added 439.58%	163,918 $18.3 Million
Q2 2020 Aug 14, 2020	SELL	$68.08 - $95.68 $30,499 - $42,864	-448 Reduced 1.45%	30,379 $2.83 Million
Q1 2020 May 15, 2020	BUY	$61.71 - $101.95 $131,072 - $216,541	2,124 Added 7.4%	30,827 $2.26 Million
Q4 2019 Feb 14, 2020	BUY	$70.08 - $84.64 $44,010 - $53,153	628 Added 2.24%	28,703 $2.41 Million
Q3 2019 Nov 14, 2019	BUY	$62.38 - $85.89 $451,444 - $621,585	7,237 Added 34.73%	28,075 $2.36 Million
Q2 2019 Aug 15, 2019	BUY	$53.64 - $65.42 $94,835 - $115,662	1,768 Added 9.27%	20,838 $0
Q1 2019 May 14, 2019	BUY	$49.38 - $70.58 $20,739 - $29,643	420 Added 2.25%	19,070 $0
Q4 2018 Feb 13, 2019	BUY	$46.97 - $63.98 $331,138 - $451,059	7,050 Added 60.78%	18,650 $987,000
Q3 2018 Nov 14, 2018	BUY	$43.25 - $63.74 $501,700 - $739,384	11,600 New	11,600 $0

Others Institutions Holding MEDP

# of Institutions

617

Shares Held

25.1M

Call Options Held

42.8K

Put Options Held

207K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $9.66B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Medpace Holdings, Inc. Transaction History